157 related articles for article (PubMed ID: 19773439)
1. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
Lin CJ; Malina A; Pelletier J
Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439
[TBL] [Abstract][Full Text] [Related]
2. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
3. The Myc oncoprotein as a therapeutic target for human cancer.
Vita M; Henriksson M
Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
[TBL] [Abstract][Full Text] [Related]
4. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules.
Kiessling A; Sperl B; Hollis A; Eick D; Berg T
Chem Biol; 2006 Jul; 13(7):745-51. PubMed ID: 16873022
[TBL] [Abstract][Full Text] [Related]
6. Of Myc and Mnt.
Hooker CW; Hurlin PJ
J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
[TBL] [Abstract][Full Text] [Related]
7. Cancer therapeutics: targeting the dark side of Myc.
Ponzielli R; Katz S; Barsyte-Lovejoy D; Penn LZ
Eur J Cancer; 2005 Nov; 41(16):2485-501. PubMed ID: 16243519
[TBL] [Abstract][Full Text] [Related]
8. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.
Lin CJ; Nasr Z; Premsrirut PK; Porco JA; Hippo Y; Lowe SW; Pelletier J
Cell Rep; 2012 Apr; 1(4):325-33. PubMed ID: 22573234
[TBL] [Abstract][Full Text] [Related]
9. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
Bitterman PB; Polunovsky VA
Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
[TBL] [Abstract][Full Text] [Related]
10. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
Murooka TT; Rahbar R; Fish EN
Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation.
Sundberg TB; Ney GM; Subramanian C; Opipari AW; Glick GD
Cancer Res; 2006 Feb; 66(3):1775-82. PubMed ID: 16452238
[TBL] [Abstract][Full Text] [Related]
12. The eukaryotic initiation factor 4E-binding proteins and apoptosis.
Proud CG
Cell Death Differ; 2005 Jun; 12(6):541-6. PubMed ID: 15818413
[No Abstract] [Full Text] [Related]
13. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
Pelletier J; Graff J; Ruggero D; Sonenberg N
Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
[TBL] [Abstract][Full Text] [Related]
14. Developing anti-neoplastic biotherapeutics against eIF4F.
Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
[TBL] [Abstract][Full Text] [Related]
15. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
[TBL] [Abstract][Full Text] [Related]
17. Myc, cell competition, and compensatory proliferation.
Gallant P
Cancer Res; 2005 Aug; 65(15):6485-7. PubMed ID: 16061622
[TBL] [Abstract][Full Text] [Related]
18. New Myc-anisms for DNA replication and tumorigenesis?
Lebofsky R; Walter JC
Cancer Cell; 2007 Aug; 12(2):102-3. PubMed ID: 17692801
[TBL] [Abstract][Full Text] [Related]
19. Acting locally and globally: Myc's ever-expanding roles on chromatin.
Varlakhanova NV; Knoepfler PS
Cancer Res; 2009 Oct; 69(19):7487-90. PubMed ID: 19773445
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat.
Dong Y; Tu R; Liu H; Qing G
Signal Transduct Target Ther; 2020 Jul; 5(1):124. PubMed ID: 32651356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]